Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
04/2002
04/23/2002US6376243 Capable of specifically hybridizing with a sequence included within the sequence of a nucleic acid molecule encoding a mammalian 5-ht4b receptor.
04/23/2002US6376228 Heterophil-adapted poultry vaccine
04/23/2002US6376215 JMY, a co-activator for p300/CBP, nucleic acid encoding JMY and uses thereof
04/23/2002US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto
04/18/2002WO2002031168A2 Minimal adenoviral vector and recombinant vaccines based thereon
04/18/2002WO2002031157A2 Shrimp alkaline phosphatase
04/18/2002WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation
04/18/2002WO2002030981A1 Gene encoding a human g-protein coupled receptor and its use
04/18/2002WO2002030965A2 Nucleic acids encoding stichodactylidae chromoproteins
04/18/2002WO2002030471A2 A novel system for the evaluation of the activity and/or specificity of a viral component
04/18/2002WO2002030185A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same
04/18/2002WO2002030183A1 Genetic control of sex ratio in animal populations
04/18/2002WO2002001949A3 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof
04/18/2002WO2001079452A3 Tolerance-inducing thy-marrow composite tissue construct and organ
04/18/2002WO2001077357A3 Chromosomal vectors and uses thereof
04/18/2002WO2001072777A3 Human transcription factors
04/18/2002WO2001064876A3 Human schizophrenia gene
04/18/2002WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof
04/18/2002US20020046414 In vivo electroporation method for early stage embryo of aves
04/18/2002US20020046412 Use for finding active compounds for crop protection
04/18/2002US20020046411 In vivo animal model of human leukemia
04/18/2002US20020046410 Method for generating immune-compatible cells and tissues using nuclear transfer techniques
04/18/2002US20020046409 Roles for Nkx3.1 in prostate development and cancer
04/18/2002US20020045258 Methods to prepare and use epidermal stem cells
04/18/2002US20020045257 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells
04/18/2002US20020045253 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines
04/18/2002US20020045241 T cells specific for kidney carcinoma
04/18/2002US20020045213 IL-17 receptor like molecules and uses thereof
04/18/2002US20020045166 Peptides; for use as tools in gene therapy
04/18/2002US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines
04/18/2002CA2425318A1 Far red shifted fluorescent proteins
04/18/2002CA2425293A1 A novel system for the evaluation of the activity and/or specificity of a viral component
04/18/2002CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation
04/18/2002CA2424901A1 Genetic control of sex ratio in animal populations
04/18/2002CA2424821A1 Gene encoding a human g-protein coupled receptor and its use
04/18/2002CA2393680A1 A schizophrenic model animal with sensorimotor and behavioral abnormalities and a method for preparing the same
04/17/2002EP1197567A2 Characterisation of gene function using double stranded RNA inhibition
04/17/2002EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
04/17/2002EP1197144A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases
04/17/2002EP1197143A1 Goodpasture's syndrome model mouse
04/17/2002EP1196635A2 Cell death related drug targets in yeast and fungi
04/17/2002EP1196583A2 GENOME SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS $i(ABISSY), FRAGMENT AND USES THEREOF
04/17/2002EP1196560A1 Neurotrophic factor receptor gfr-alpha-4
04/17/2002EP1196426A1 Cytoplasmic transfer to de-differentiate recipient cells
04/17/2002EP1196153A2 Process for the improvement of spermatozoa fertilization activity
04/17/2002EP1196027A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
04/17/2002EP1196026A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
04/17/2002EP0580606B1 Method for delivering the direct feed microorganism lactobacillus reuteri to avian organisms in ovo
04/17/2002CN1344796A Implantation method of sex-linked balance lethal and sex control gene for Bombyx mori
04/16/2002US6374130 Methods for tracking the progression of Alzheimer's disease identifying treatment using transgenic mice
04/16/2002US6372959 Expression vector of a mud loach growth hormone gene
04/16/2002US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use
04/16/2002US6372956 Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor
04/16/2002US6372468 Useful in the development of human therapeutics and diagnostic formulations
04/16/2002US6372422 Creating superovulation in non-human female mammal to create eggs by using an ovulatory pharmaceutical; determining sex of sperm cell of male mammal; sorting according to sex of sperm cells; inserting into uterus; fertilization to produce embryos
04/11/2002WO2002029104A2 Tumor marker and methods of use
04/11/2002WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue
04/11/2002WO2002029075A2 Multiple inducible gene regulation system
04/11/2002WO2002029002A2 Method for generating cloned animals using chromosome shuffling
04/11/2002WO2002028897A2 Human g-protein coupled receptor and uses thereof
04/11/2002WO2002028891A2 Listeria inocua, genome and applications
04/11/2002WO2002028311A1 System of hysteroscopic insemination of mares
04/11/2002WO2002028188A1 Derivation of human tumor cell lines using passage in transgenic mice having selectable markers
04/11/2002WO2002028164A2 Cloning endangered and extinct species
04/11/2002WO2002012441A3 Cryopreservation of sperm
04/11/2002WO2002009650A3 Methods and compositions for the repair and/or regeneration of damaged myocardium
04/11/2002WO2002003911A3 Prevention and treatment of alzheimer's disease
04/11/2002WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
04/11/2002WO2001070174A3 Vegf-modulated genes and methods employing them
04/11/2002CA2425100A1 Method for generating cloned animals using chromosome shuffling
04/11/2002CA2425076A1 Cloning endangered and extinct species
04/11/2002CA2424952A1 Listeria inocua, genome and applications
04/11/2002CA2424178A1 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
04/11/2002CA2424115A1 System of hysteroscopic insemination of animals
04/10/2002EP1195435A1 Truncated phosphodiesterase-7 polypeptides
04/10/2002EP1194570A1 Fusion proteins incorporating lysozyme
04/10/2002EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein
04/10/2002EP1194447A2 Novel potassium channels and genes encoding these potassium channels
04/10/2002EP1021717B1 Method of sorting birds in ovo
04/10/2002CN2484743Y Silkworm hatcher
04/10/2002CN1082337C Feeds compsn and nutritious agent contg. triterpenic saponin extract
04/09/2002US6369295 Uses of transgenic mouse containing a type X collagen mutant
04/09/2002US6369294 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines
04/09/2002US6369059 Tetracyclic derivatives, process of preparation and use
04/09/2002US6369027 Osteoprotegerin
04/09/2002US6368842 An isolated nucleic acid; therapy for neuroblastomas in infant brains, uterus, lung, ovary adenocarcinomas and leukocytes
04/09/2002US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences
04/09/2002US6368811 Syndecan interacting proteins and the use thereof
04/09/2002US6368572 Use of hematopoietic deficient cell transplanted chimeric nonhuman mammals as human bacterial toxin shock models
04/09/2002CA1341356C Transkaryotic implantation
04/06/2002CA2358239A1 Novel siglec-like gene
04/06/2002CA2358235A1 Novel siglec gene
04/04/2002WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
04/04/2002WO2002026954A2 Truncated phosphodiesterase-7 polypeptides
04/04/2002WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
04/04/2002WO2002026820A2 Immunomodulatory protein derived from the yaba monkey tumor virus
04/04/2002WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
04/04/2002WO2001094610A3 Binary hybrid mutational vectors
04/04/2002WO2001091575A8 Animal food and method